Drug Shortage Report for FERRLECIT

Last updated on 2023-03-06 History
Report ID 181813
Drug Identification Number 02243333
Brand name FERRLECIT
Common or Proper name FERRLECIT
Company Name SANOFI-AVENTIS CANADA INC
Market Status MARKETED
Active Ingredient(s)
Strength(s) 12.5MG
Dosage form(s) SOLUTION LIQUID
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 10
ATC code B03AC
ATC description IRON PREPARATIONS
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2023-01-18
Estimated end date 2023-03-31
Actual end date 2023-03-02
Shortage status Resolved
Updated date 2023-03-06
Company comments Supply delay. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date.
Health Canada comments
Tier 3 Status No
Company contact information email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2023-03-06 French Compare
v8 2023-03-06 English Compare
v7 2023-02-27 French Compare
v6 2023-02-27 English Compare
v5 2023-01-19 French Compare
v4 2023-01-19 English Compare
v3 2023-01-19 French Compare
v2 2023-01-19 French Compare
v1 2023-01-19 English Compare

Showing 1 to 9 of 9